Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

CVS HEALTH (CVS)
Mes dernières consult.
Most popular
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

CVS Health : Today's Research Reports on Stocks to Watch: CVS Health and Walgreens Boots Alliance

share with twitter share with LinkedIn share with facebook
share via e-mail
0
06/19/2017 | 02:05pm CEST

NEW YORK, NY / ACCESSWIRE / June 19, 2017 / Even pharmacy chains like CVS Health Corp.'s and Walgreens Boots Alliance's shares were shaky after Amazon announced its deal to acquire Whole Foods. Grocery stores and pharmacy chains were feeling the pressure after Friday's big announcement. Despite the acquisition not directly affecting CVS nor Walgreens, the two stocks saw shares drop as investors cautiously wait to see if there will be any potential threat. It also doesn't help that a CNBC report back in May had indicated that Amazon may also be interesting in launching its own delivery and online pharmacy business.

RDI Initiates Coverage on:

CVS Health Corporation
https://ub.rdinvesting.com/news/?ticker=CVS

Walgreens Boots Alliance, Inc.
https://ub.rdinvesting.com/news/?ticker=WBA

CVS Health Corporation's (NYSE: CVS) shares closed down 3.78% on Friday on trading volume more than twice as large as usual. CVS was among other pharmacy stocks to drop after Amazon announced it was buying Whole Foods. Traders now may have reason to worry that the online retail giant may be choosing pharmaceutical sales as the next thing to break into. CVS also recently reported a 4.7% decrease in same-store sales in its Q1 report which was not that assuring for traders. In other news the company did announce that in partnership with Drug Store News and Mack Elevation, it will hold an innovation summit that brings together leaders from major healthcare, technology and consumer brands including Facebook, Under Armour, Google and IBM. The summit will be for a discussion about emerging trends that are helping reshape the health care industry.

Access RDI's CVS Health Research Report at:
https://ub.rdinvesting.com/news/?ticker=CVS

Walgreens Boots Alliance, Inc.'s shares closed down 4.99% on Friday after the big Amazon news. Plus investors weren't thrilled over some pessimistic updates on its ongoing potential merger with Rite-Aid. The merger has been now in the process for about 1.5 years. A Street.com report indicated that a SEC filing by Rite Aid didn't have an upbeat tone about completing the deal. The Federal Trade Commission is expected to resolve its antitrust review of the merger before July 4th. Chairman Maureen Ohlhausen and Terrell McSweeny are two sitting members that are left who need to vote to challenge the deal before the 7th of next month. If they don't, Walgreens will able to consummate the deal. Traders are eagerly waiting for the FTC's decision.

Access RDI's Walgreens Boots Alliance Research Report at:
https://ub.rdinvesting.com/news/?ticker=WBA

Our Actionable Research on CVS Health Corporation (NYSE: CVS) and Walgreens Boots Alliance, Inc. (NASDAQ: WBA) can be downloaded free of charge at Research Driven Investing.

Research Driven Investing

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of RDInvesting.com and reviewed by Nadia Noorani, CFA® charter holder. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

[email protected]

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: RDInvesting.com


© Accesswire 2017
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH
10/20 CVS HEALTH : Dividend Coverage: This Pharmacy Company has a Dividend Yield of 2...
10/19 CVS HEALTH : SilverScript Insurance Company, a CVS Health Company, Introduces Ne..
10/19 EXPRESS SCRIPTS : Anthem will turn to CVS for prescriptions
10/19 EXPRESS SCRIPTS : Anthem to turn to CVS after troubled deal
10/19DJAnthem To Launch Pharmacy Benefit Manager -- WSJ
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--3rd Update
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
10/18 MARKETS RIGHT NOW : US stocks closing higher; IBM surges
10/18 Anthem will turn to CVS after troubled Express Scripts deal
10/18DJAnthem to Launch Its Own Pharmacy-Benefit Manager--2nd Update
More news
News from SeekingAlpha
10/19 Dividend Growth Stocks Going Ex-Div October 23th-27th
10/19 Stocks Going Ex-Dividend The Fourth Week Of October
10/18 PHARMACY BEARS : High On Drugs
10/18 CVS Health inks five-year deal with Anthem to support PBM unit; shares up 2% ..
10/17 A REAL DIVIDEND GROWTH MACHINE : Q3 2017 Portfolio Review
Financials ($)
Sales 2017 184 B
EBIT 2017 10 051 M
Net income 2017 5 266 M
Debt 2017 24 750 M
Yield 2017 2,61%
P/E ratio 2017 14,75
P/E ratio 2018 12,82
EV / Sales 2017 0,55x
EV / Sales 2018 0,52x
Capitalization 75 866 M
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 86,7 $
Spread / Average Target 16%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-5.42%75 327
WALGREENS BOOTS ALLIANCE-18.15%72 488
EXPRESS SCRIPTS HOLDING CO-16.02%33 365
MCKESSON CORPORATION6.77%30 742
CARDINAL HEALTH INC-10.10%20 394
AMERISOURCEBERGEN CORP.5.13%17 636